Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$702M |
| 2 |
Applied Materials
AMAT
|
+$507M |
| 3 |
Keurig Dr Pepper
KDP
|
+$387M |
| 4 |
KeyCorp
KEY
|
+$383M |
| 5 |
Visa
V
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Broadcom
AVGO
|
+$446M |
| 3 |
NXP Semiconductors
NXPI
|
+$434M |
| 4 |
Analog Devices
ADI
|
+$309M |
| 5 |
Lam Research
LRCX
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.22% |
| 2 | Technology | 4.92% |
| 3 | Industrials | 4.28% |
| 4 | Consumer Discretionary | 4.13% |
| 5 | Healthcare | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
CALL
TripAdvisor
TRIP
$1.28B
| $21M | 0.01% |
376,800
+157,900
| +72% | +$7.55M |
|
|
DRNA
1202
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $21M | 0.01% |
1,712,315
+1,541,574
| +903% | +$19.4M |
|
1203
CALL
Sony
SONY
$142B
| $21M | 0.01% |
2,044,500
+1,378,000
| +207% | +$13.4M |
|
|
WW
1204
PUT
DELISTED
WW International
WW
| $21M | 0.01% |
207,300
+37,200
| +22% | +$2.92M |
|
1205
CALL
Twilio
TWLO
$36.2B
| $20.9M | 0.01% |
373,700
+120,200
| +47% | +$5.95M |
|
1206
CALL
Marathon Petroleum
MPC
$101B
| $20.9M | 0.01% |
298,300
+60,900
| +26% | +$4.65M |
|
1207
CALL
C.H. Robinson
CHRW
$17.4B
| $20.9M | 0.01% |
249,600
-112,100
| -31% | -$10M |
|
1208
Okta
OKTA
$26B
| $20.9M | 0.01% |
414,067
+244,267
| +144% | +$11.6M |
|
|
PX
1209
PUT
DELISTED
Praxair Inc
PX
| $20.8M | 0.01% |
131,700
+46,300
| +54% | +$7.15M |
|
|
PPLI
1210
PUT
People Inc
PPLI
$3.02B
| $20.8M | 0.01% |
763,214
+84,491
| +12% | +$2.31M |
|
1211
CALL
Trip.com Group
TCOM
$28.3B
| $20.8M | 0.01% |
436,200
+227,400
| +109% | +$10.3M |
|
1212
CALL
International Paper
IP
$21.6B
| $20.7M | 0.01% |
420,288
+191,453
| +84% | +$9.78M |
|
1213
Texas Roadhouse
TXRH
$13.6B
| $20.7M | 0.01% |
315,771
+197,865
| +168% | +$12.4M |
|
1214
Euronet Worldwide
EEFT
$2.75B
| $20.7M | 0.01% |
246,632
+190,848
| +342% | +$15.4M |
|
1215
Nektar Therapeutics
NKTR
$2.53B
| $20.7M | 0.01% |
28,206
+28,067
| +20,192% | +$32.4M |
|
1216
CALL
Caesars Entertainment
CZR
$6.06B
| $20.6M | 0.01% |
527,900
+518,800
| +5,701% | +$21.4M |
|
|
EGRX
1217
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $20.6M | 0.01% |
272,806
-97,990
| -26% | -$6.16M |
|
1218
Chemed
CHE
$6.94B
| $20.6M | 0.01% |
+64,090
| New | +$20.1M |
|
1219
CNX Resources
CNX
$5.32B
| $20.6M | 0.01% |
1,159,587
+1,063,347
| +1,105% | +$17.1M |
|
1220
CALL
Nucor
NUE
$61.9B
| $20.6M | 0.01% |
329,800
-341,300
| -51% | -$21.8M |
|
1221
PUT
Stryker
SYK
$130B
| $20.6M | 0.01% |
122,000
+79,700
| +188% | +$13.4M |
|
1222
CALL
Mattel
MAT
$4.29B
| $20.6M | 0.01% |
1,252,600
-156,400
| -11% | -$2.37M |
|
1223
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
| $20.5M | 0.01% |
446,286
+394,434
| +761% | +$18.6M |
|
1224
CALL
Colgate-Palmolive
CL
$73.5B
| $20.5M | 0.01% |
316,500
-125,600
| -28% | -$8.22M |
|
1225
PUT
United States Oil Fund
USO
$1.77B
| $20.5M | 0.01% |
170,150
-120,063
| -41% | -$13.2M |
|
Similar funds
Ken Griffin's Q2 2018 Portfolio in Review
As of Q2 2018, Ken Griffin held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,159 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.
By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 5% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.
- Ken Griffin's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
- Ken Griffin added most to Citigroup in Q2 2018, an estimated $702M increase.
- Ken Griffin's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
- Ken Griffin fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
- Ken Griffin's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
- Ken Griffin opened 1,572 new positions and closed 1,012 in Q2 2018.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $203B.
Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.